Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020

Angela M. Parcesepe; Melissa Stockton; Molly Remch; C. William Wester; Charlotte Bernard; Jeremy Ross; Andreas D. Haas; Rogers Ajeh; Keri N. Althoff; Leslie Enane; William Pape; Albert Minga; Edith Kwobah; Mpho Tlali; Junko Tanuma; Dominique Nsonde; Aimee Freeman; Stephany N. Duda; Denis Nash; Kathryn Lancaster

doi:10.1002/jia2.26147

journal article Open Access Aug 01, 2023

Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020

Angela M. Parcesepe Melissa Stockton Molly Remch C. William Wester

Charlotte Bernard

Jeremy Ross Andreas D. Haas

Rogers Ajeh Keri N. Althoff Leslie Enane

William Pape Albert Minga

Edith Kwobah Mpho Tlali Junko Tanuma

Dominique Nsonde Aimee Freeman Stephany N. Duda Denis Nash

Kathryn Lancaster

Journal of the International AIDS Society Vol. 26 No. 8 · Wiley

View at Publisher Save 10.1002/jia2.26147

Abstract

AbstractIntroductionCommon mental disorders (CMDs) are highly prevalent among people with HIV. Integrating mental healthcare into HIV care may improve mental health and HIV treatment outcomes. We describe the reported availability of screening and treatment for depression, anxiety and post‐traumatic stress disorder (PTSD) at global HIV treatment centres participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium in 2020 and changes in availability at sites in low‐ or middle‐income countries (LMICs) between 2016/2017 and 2020.MethodsIn 2020, 238 sites contributing individual‐level data to the IeDEA Consortium and in 2016/2017 a stratified random sample of IeDEA sites in LMICs were eligible to participate in site surveys on the availability of screening and treatment for CMDs. We assessed trends over time for 68 sites across 27 LMICs that participated in both surveys.ResultsAmong the 238 sites eligible to participate in the 2020 site survey, 227 (95%) participated, and mental health screening and treatment data were available for 223 (98%) sites across 41 countries. A total of 95 sites across 29 LMICs completed the 2016/2017 survey. In 2020, 68% of sites were in urban settings, and 77% were in LMICs. Overall, 50%, 14% and 12% of sites reported screening with a validated instrument for depression, anxiety and PTSD, respectively. Screening plus treatment in the form of counselling was available for depression, anxiety and PTSD at 46%, 13% and 11% of sites, respectively. Screening plus treatment in the form of medication was available for depression, anxiety and PTSD at 36%, 11% and 8% of sites, respectively. Among sites that participated in both surveys, screening for depression was more commonly available in 2020 than 2016/2017 (75% vs. 59%, respectively,p= 0.048).ConclusionsReported availability of screening for depression increased among this group of IeDEA sites in LMICs between 2016/2017 and 2020. However, substantial gaps persist in the availability of mental healthcare at HIV treatment sites across global settings, particularly in resource‐constrained settings. Implementation of sustainable strategies to integrate mental health services into HIV care is needed.

Topics

No keywords indexed for this article. Browse by subject →

References

49

[1]

10.1007/s11904-021-00583-w

[2]

10.1007/s10461-019-02706-2

[3]

10.1016/j.cpr.2016.11.005

[4]

10.3389/fpsyt.2020.00834

[5]

Rezaei S "Global prevalence of depression in HIV/AIDS: a systematic review and meta‐analysis" BMJ Support Palliat Care (2019) 10.1136/bmjspcare-2019-001952

[6]

10.1007/s11126-020-09849-9

[7]

10.1371/journal.pone.0181960

[8]

10.1016/j.eclinm.2020.100621

[9]

10.1002/jia2.25842

[10]

10.1037/hea0000606

[11]

10.1007/s10461-018-02390-8

[12]

10.1016/s2214-109x(20)30279-5

[13]

10.1016/j.jad.2013.04.018

[14]

10.1016/j.jad.2020.03.068

[15]

10.1016/s2215-0366(19)30511-5

[16]

10.1017/s2045796012000261

[17]

10.1016/s0140-6736(07)61242-2

[18]

10.1002/da.22711

[19]

10.1017/s0033291717003336

[20]

Mental health in the Americas: an overview of the treatment gap

Robert Kohn, Ali Ahsan Ali, Victor Puac-Polanco et al.

Revista Panamericana de Salud Pública 10.26633/rpsp.2018.165

[21]

Failure and Delay in Initial Treatment Contact After First Onset of Mental Disorders in the National Comorbidity Survey Replication

Philip S. Wang, Patricia Berglund, Mark Olfson et al.

Archives of General Psychiatry 10.1001/archpsyc.62.6.603

[22]

10.1017/s2045796021000196

[23]

10.1097/qad.0000000000002227

[24]

World Health Organization (2016)

[25]

Kohn R "The treatment gap in mental health care" Bull World Health Organ (2004)

[26]

10.3402/gha.v7.23431

[27]

10.1371/journal.pmed.1001447

[28]

International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012–2019

Frédérique Chammartin, Cam Ha Dao Ostinelli, Kathryn Anastos et al.

BMJ Open 10.1136/bmjopen-2019-035246

[29]

10.1093/ije/dyl286

[30]

10.1371/journal.pone.0268167

[31]

10.1002/jia2.25101

[32]

Challenges and Opportunities in Global Mental Health: a Research-to-Practice Perspective

Milton L. Wainberg, Pamela Scorza, James M. Shultz et al.

Current Psychiatry Reports 10.1007/s11920-017-0780-z

[33]

10.1136/ebmental-2020-300199

[34]

10.1093/aje/kwx323

[35]

10.1016/s0140-6736(18)32205-0

[36]

10.9745/ghsp-d-20-00607

[37]

10.7448/ias.20.4.21497

[38]

10.1002/jia2.25705

[39]

10.1186/1471-2458-13-835

[40]

10.1017/s1352465813000015

[41]

10.1515/ijamh‐2019‐0037

[42]

10.1186/s12913-020-05750-0

[43]

10.3402/gha.v8.27942

[44]

10.1007/s10461-014-0727-x

[45]

10.2190/pm.43.2.a

[46]

10.1186/s12913-018-3388-z

[47]

10.1371/journal.pone.0231872

[48]

10.1371/journal.pone.0153132

[49]

10.1186/s12913-021-06499-w

Cited By

13

Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study

Francesco Di Gennaro, Roberta Papagni · 2024

BMC Infectious Diseases

Metrics

13

Citations

49

References

Details

Published: Aug 01, 2023
Vol/Issue: 26(8)
License: View

Authors

A

Angela M. Parcesepe

Department of Maternal and Child Health University of North Carolina at Chapel Hill Chapel Hill North Carolina USA; University of North Carolina at Chapel Hill Carolina Population Center Chapel Hill North Carolina USA

M

Melissa Stockton

Department of Psychiatry Columbia University New York New York USA

M

Molly Remch

Department of Epidemiology University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

C

C. William Wester

Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

C

Charlotte Bernard

University of Bordeaux National Institute for Health and Medical Research Research Institute for Sustainable Development Bordeaux Population Health Research Centre Bordeaux France

J

Jeremy Ross

TREAT Asia/amfAR The Foundation for AIDS Research Bangkok Thailand

A

Andreas D. Haas

University of Bern Institute of Social and Preventive Medicine Bern Switzerland

R

Rogers Ajeh

Clinical Research Education and Networking Consultancy Yaounde Cameroon

K

Keri N. Althoff

Johns Hopkins University Bloomberg School of Public Health Baltimore Maryland USA

L

Leslie Enane

Department of Pediatrics The Ryan White Center for Pediatric Infectious Disease and Global Health Indiana University School of Medicine Indianapolis Indiana USA

W

William Pape

Groupe Haitien d''Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) Port au Prince Haiti

A

Albert Minga

Centre Medical de Suivi de Donneurs de Sang/CNTS/PRIMO‐CI Abidjan Cote D''Ivoire

E

Edith Kwobah

Department of Mental Health Moi Teaching and Referral Hospital Eldoret Kenya

M

Mpho Tlali

Centre for Infectious Disease Epidemiology & Research (CIDER) School of Public Health & Family Medicine University of Cape Town Cape Town South Africa

J

Junko Tanuma

Division of the AIDS Medical Information of AIDS Clinical Care National Center for Global Health and Medicine Tokyo Japan

D

Dominique Nsonde

CTA Brazzaville Brazzaville Congo

A

Aimee Freeman

Johns Hopkins University Bloomberg School of Public Health Baltimore Maryland USA

S

Stephany N. Duda

Department of Biomedical Informatics Vanderbilt University School of Medicine Nashville Tennessee USA

D

Denis Nash

City University of New York Institute for Implementation Science in Population Health New York New York USA

K

Kathryn Lancaster

Department of Epidemiology The Ohio State University Columbus Ohio USA

Funding

National Institute of Allergy and Infectious Diseases Award: R24AI24872

National Institute of Mental Health Award: K01MH114721

Eunice Kennedy Shriver National Institute of Child Health and Human Development Award: P2CHD050924

Cite This Article

Angela M. Parcesepe, Melissa Stockton, Molly Remch, et al. (2023). Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020. Journal of the International AIDS Society, 26(8). https://doi.org/10.1002/jia2.26147

Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020

You May Also Like